Platinum Investment Management’s Blueprint Medicines BPMC Stock Holding History

Platinum Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,018	Closed	-$476K	–	139
2024 Q1	$476K	Hold	5,018	–	–	0.02%	94
2023 Q4	$463K	Hold	5,018	–	–	0.02%	98
2023 Q3	$252K	Sell	5,018 -51,153	-91%	-$2.73M	0.01%	100
2023 Q2	$3.55M	Hold	56,171	–	–	0.12%	66
2023 Q1	$2.53M	Buy	56,171 +16,329	+41%	+$736K	0.09%	77
2022 Q4	$1.75M	Buy	39,842 +6,980	+21%	+$335K	0.07%	83
2022 Q3	$2.17M	Sell	32,862 -7,142	-18%	-$459K	0.09%	74
2022 Q2	$2.02M	Buy	40,004 +12,883	+48%	+$755K	0.08%	83
2022 Q1	$1.73M	Hold	27,121	–	–	0.05%	88
2021 Q4	$2.9M	Hold	27,121	–	–	0.08%	84
2021 Q3	$2.79M	Hold	27,121	–	–	0.08%	86
2021 Q2	$2.39M	Hold	27,121	–	–	0.06%	89
2021 Q1	$2.64M	Hold	27,121	–	–	0.06%	77
2020 Q4	$3.04M	Sell	27,121 -12,390	-31%	-$1.31M	0.07%	71
2020 Q3	$3.66M	Hold	39,511	–	–	0.09%	62
2020 Q2	$3.08M	Hold	39,511	–	–	0.07%	66
2020 Q1	$2.31M	Buy	39,511 +20,417	+107%	+$1.31M	0.06%	68
2019 Q4	$1.53M	Buy	19,094 +6,348	+50%	+$475K	0.03%	74
2019 Q3	$936K	Hold	12,746	–	–	0.02%	84
2019 Q2	$1.2M	Hold	12,746	–	–	0.03%	79
2019 Q1	$1.02M	Buy	+12,746	New	+$942K	0.02%	88

Other funds holding BPMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Platinum Investment Management's BPMC Position: Q2 2024 in Review

Platinum Investment Management sold out of Blueprint Medicines (BPMC) in Q2 2024, closing a stake of 5,018 shares — an estimated $476K sold.

Platinum Investment Management first reported a position in BPMC in Q1 2019 and held it in 21 quarters. The position peaked at $3.66M in Q3 2020. 305 funds tracked by Wall St. Rank hold BPMC as of Q2 2024.

Platinum Investment Management reported no remaining Blueprint Medicines position as of Q2 2024 after selling out during the quarter.
Platinum Investment Management sold 5,018 Blueprint Medicines shares in Q2 2024, an estimated $476K.
Platinum Investment Management first reported a position in Blueprint Medicines in Q1 2019 and held it in 21 quarters.
Platinum Investment Management's Blueprint Medicines position peaked at $3.66M in Q3 2020.
305 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2024.

Based on Platinum Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.